AtriCure (ATRC) Peer Comparison

$58.97

$-0.33 (-0.56%)

As on 23-Oct-2026 16:00EDT

Market cap

$3,000 Mln

Revenue (TTM)

$570 Mln

P/E Ratio

280.8

P/B Ratio

5.8

Div. Yield

0 %

Edit

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Market cap ($ Mln)	3,000	12,800	11,233	11,600	10,422
Revenue ($ Mln)	570	1,505	785	6,561	613
Net Profit ($ Mln)	10.55	160.59	41.54	-578.00	-188.05
Net Margin (%)	1.85	10.67	5.29	-8.81	-30.68
RoE (%)	2.09	10.86	1.97	-10.33	-28.10
Price to Earnings	280.81	79.84	242.37	--	--
Price-To-Book	5.79	8.22	4.41	1.77	13.27

Income Statement ($ Mln)

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Operating Revenue	569.62	1,504.87	785.10	6,561.10	612.84
Cost of Revenue	135.77	483.98	384.30	4,473.00	127.96
Gross Profit	397.74	942.44	347.62	2,139.40	393.22
Operating Expenses	419.96	833.56	335.50	2,373.70	565.37
Operating Profit (EBIT)	13.89	187.34	65.30	-285.60	-80.49
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	12.09	203.83	52.15	-472.00	-192.83
Provision for Tax	1.54	43.24	10.61	106.00	-4.79
Profit after Tax (Net Income)	10.55	160.59	41.54	-578.00	-188.05
Minority Interest	0.00	0.00	0.00	0.00	0.00
Consolidated Profit	0.00	93.19	0.00	0.00	0.00

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Shareholder's Funds	516.43	1,530.77	2,112.03	5,630.20	682.49
Minority Interest	0.00	0.00	0.00	0.00	0.00
Non-Current Liabilities	78.29	210.18	705.49	4,583.70	135.71
Current Liabilities	81.92	233.78	132.66	1,382.00	102.33
Total Liabilities	654.18	1,826.52	2,949.70	11,794.70	893.49

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Non-Current Assets	331.11	630.60	1,749.63	9,133.70	404.74
Current Assets	345.53	1,344.12	1,200.55	2,462.20	515.78
Total Assets	654.18	1,826.52	2,949.70	11,794.70	893.49
Total Debt*	71.05	212.71	690.94	3,697.80	102.84
Net Current Assets	263.62	1,110.35	1,067.90	1,080.20	413.45

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Cash From Operating Activities	57.33	238.66	117.42	623.80	-46.34
Cash Flow from Investing Activities	-14.55	-404.59	-298.47	-130.50	-77.61
Cash from Financing Activities	1.18	26.53	-15.21	-409.40	11.89
Net Cash Inflow / Outflow	--	--	--	--	--

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
ROCE (%)	-2.05	11.76	1.79	-5.43	-22.53
ROE (%)	2.09	10.86	1.97	-10.33	-28.10
ROA (%)	1.47	7.95	1.36	-4.08	-18.00
EBIT Margin (%)	2.96	13.63	9.87	-4.47	-30.58
Net Margin (%)	1.85	10.67	5.29	-8.81	-30.68
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Revenue Growth (%)	13.94	17.55	16.49	-1.57	41.55
EBIT Growth (%)	157.70	17.49	920.78	-129.16	-116.42
Net Profit Growth (%)	129.02	8.72	400.42	-184.08	-102.66
EPS Growth (%)	127.92	8.12	394.30	-184.11	-96.88
Book Value Growth (%)	7.70	17.33	2.16	-9.82	-12.65

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Price / Earnings	-168.89	68.93	189.42	-14.68	-34.59
Price / Book Value	5.79	8.22	4.41	1.77	13.27
Dividend Yield (%)	0.00	0.00	0.00	0.00	0.00
EV/EBITDA	77.39	56.13	63.83	121.15	-72.93
Market Cap ($ Cr)	--	--	--	--	--

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Debt to Equity	0.12	0.00	0.26	0.65	0.00
Short term debt to equity ratio	0.00	0.01	0.01	0.01	0.00
Current Ratio	4.22	5.75	9.05	1.78	5.04
Quick Ratio	3.19	3.86	7.64	1.18	4.46
Interest Coverage	2.71	157.91	1.92	-1.64	-38.31

	AtriCure (ATRC)	Penumbra (PEN)	Repligen (RGEN)	Avantor (AVTR)	Glaukos Corp (GKOS)
Debtors to sales (%)	14.04	12.65	20.09	17.36	22.67
Asset Turnover	0.79	0.74	0.26	0.46	0.59
Receivable days	43.39	46.54	72.41	58.79	60.95
Inventory Days	205.37	331.92	146.53	64.13	193.84
Payable days	138.09	26.16	29.05	58.13	60.19
Cash Conversion Cycle	110.67	352.30	189.88	64.79	194.60

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.